SCHEMBL5694115

SCHEMBL5694115

F[B-](F)(F)F.c1ccc(-n2ccnc2)cc1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 4/20 0.84
MEN1 O00255 3/20 0.72
KMT2A Q03164 3/20 0.72
TSHR P16473 2/20 0.72
ALOX15 P16050 1/20 0.72
CYP2A6 P11509 1/20 0.58
LMNA P02545 4/20 0.55
MAPT P10636 3/20 0.55
ENPP2 Q13822 1/20 0.55
MKNK1 Q9BUB5 1/20 0.55
MKNK2 Q9HBH9 1/20 0.55
NOTUM Q6P988 1/20 0.55
NPSR1 Q6W5P4 2/20 0.53
CYP11B1 P15538 2/20 0.53
CYP11B2 P19099 2/20 0.53
TDP1 Q9NUW8 2/20 0.53
IDO1 P14902 2/20 0.53
USP2 O75604 1/20 0.53
CYP19A1 P11511 1/20 0.53
ALDH1A1 P00352 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28329295 0.98 CYP3A4 (0.81) CYP3A4MEN1KMT2ATSHRALOX15
SCHEMBL451 0.92 CYP3A4 (1.00) CYP3A4MEN1KMT2ATSHRALOX15
Phosphine SCHEMBL28849690 0.90 CYP3A4 (0.95) CYP3A4MEN1KMT2ATSHRALOX15
SCHEMBL14157261 0.90 CYP3A4 (0.95) CYP3A4MEN1KMT2ATSHRALOX15
Hydrochloric Acid SCHEMBL410291 0.90 CYP3A4 (0.95) CYP3A4MEN1KMT2ATSHRALOX15
Bromide SCHEMBL1954236 0.90 CYP3A4 (0.95) CYP3A4MEN1KMT2ATSHRALOX15
Ammonia Solution, Strong SCHEMBL3848736 0.90 CYP3A4 (0.95) CYP3A4MEN1KMT2ATSHRALOX15
Hydrochloric Acid SCHEMBL8898731 0.90 CYP3A4 (0.95) CYP3A4MEN1KMT2ATSHRALOX15
Iodide SCHEMBL28722278 0.90 CYP3A4 (0.95) CYP3A4MEN1KMT2ATSHRALOX15
SCHEMBL27772775 0.88 CYP3A4 (0.84) CYP3A4MEN1KMT2ATSHRALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107236063-B A kind of preparation method of low molecular weight polytetrafluoroethylene 广州华大生物科技有限公司 2018-01-23 CN disclosed
CN-107236063-A A kind of preparation method of low molecular weight polytetrafluoroethylene 广州华大生物科技有限公司 2017-10-10 CN disclosed
US-20060167241-A1 Method for synthesizing cyclic bisdinucleoside MITSUI CHEMICALS, INC. (JP) 2006-07-27 US disclosed
EP-1645561-A1 METHOD OF SYNTHESIZING CYCLIC BISDINUCLEOSIDE Mitsui Chemicals, Inc. (JP) 2006-04-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167241-A1 Method for synthesizing cyclic bisdinucleoside NSUN2, POLR2H, POLB CYP3A4 2590/4885MEN1 467/4885KMT2A 1088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.